Business Context and Reporting Period
This Form 8-K was filed by NanoVibronix, Inc. (trading symbol: NAOV) on May 10, 2019. The registrant is a Delaware corporation with principal executive offices in Elmsford, New York. The filing reports the entry into a material definitive agreement involving the issuance of debt and equity instruments to an accredited investor.
Key Financial Metrics and Transaction Details
The filing details a specific financing transaction rather than periodic financial performance metrics. Key terms include:
- Convertible Promissory Note: Principal amount of $125,000 with an interest rate of 6% per annum.
- Warrant: Seven-year warrant to purchase 50,000 shares of common stock or Series C preferred stock.
- Warrant Exercise Price: The lesser of 80% of the exercise price of warrants issued in the first subsequent equity financing or $4.80 per share.
- Note Conversion Price: Upon maturity or qualified financing, the lesser of 80% of the price per share in the financing (or estimated value) or $4.00 per share, with a floor of $1.00 per share.
- Dilution Cap: The aggregate shares issuable upon warrant exercise and note conversion cannot exceed 9.9% of total shares outstanding immediately preceding issuance.
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or liquidity positions.
Material Changes Versus Prior Period
This filing represents a discrete event regarding capital structure rather than a comparison of operational performance against a prior period. The material change is the creation of a direct financial obligation of $125,000 and the potential issuance of up to 50,000 additional shares via the warrant.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The filing does not contain forward-looking guidance, revenue projections, or management commentary on future operations.
Risks and Contingencies:
- Qualified Financing Trigger: The Note becomes due and payable (or convertible) upon the earlier of the 5-year anniversary or the completion of a "Qualified Financing" (aggregate proceeds of at least $2,000,000).
- Conversion Mechanics: The investor has the option to receive cash or shares upon maturity, introducing uncertainty regarding future cash outflows versus equity dilution.
- Beneficial Ownership Limit: The warrant holder cannot exercise if it would result in beneficial ownership exceeding 9.99% of outstanding shares.
Important Facts for Investor Verification
- Verify the company's current cash position to assess the ability to repay the $125,000 principal plus accrued interest if a Qualified Financing does not occur within five years.
- Monitor the company's progress toward raising a "Qualified Financing" of at least $2,000,000, as this event triggers the conversion or repayment of the Note.
- Review the fully diluted share count to understand the potential dilution impact of the 50,000 warrant shares and the note conversion, capped at 9.9% of pre-transaction outstanding shares.
- Confirm the status of the registration statement for the warrant shares, as cashless exercise is permitted if no effective registration statement exists after six months.